πŸ‡ΊπŸ‡Έ FDA
Patent

US 10524458

Humanized C3 animals

granted A61KA61K49/0008

Quick answer

US patent 10524458 (Humanized C3 animals) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K49/0008